Immix Biopharma, Inc. (IMMX)
NASDAQ·Healthcare·Biotechnology
$8.07
+0.12%
Mkt Cap $705.50M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$23.67
Range $20.00 – $26.00
Implied Upside
+193.3%
Consensus $23.67 vs current $8.07
NASDAQ·Healthcare·Biotechnology
$8.07
+0.12%
Mkt Cap $705.50M
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$23.67
Range $20.00 – $26.00
+193.3%
Consensus $23.67 vs current $8.07